下载本文档
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
Hotline:400-820-3792Inhibitors • ScreeningLibraries • Proteinswww.MedChemEMA203Cat.No.:HY-179157分子式:C₃₈H₄₅N₉O₈分子量:755.82作用靶点:PROTACs;CheckpointKinase(Chk);DNA/RNASynthesis;Apoptosis;Bcl-2Family;Caspase作用通路:PROTAC;CellCycle/DNADamage;Apoptosis储存方式:PleasestoretheproductundertherecommendedconditionsintheCertificateofAnalysis.BIOLOGICALACTIVITY生物活性MA203是一种高效且选择性的PROTAC降解剂,靶向CHK1。MA203可加速实体瘤细胞和急性白血病细胞中CHK1的CRBN依赖性蛋白酶体降解。MA203可诱导DNA复制应激。MA203可阻断细胞周期进程并诱导肿瘤细胞凋亡(apoptosis)。MA203不会损伤健康的已分化和原始造血细胞、基质细胞以及视网膜上皮细胞。MA203可用于CHK1依赖性癌症的研究[1]。IC50&TargetChk1BaxBcl-xL体外研究MA203(PROTAC41)reducesCHK1levelsby-50%at5µMinMIAPaCa-2pancreaticductaladenocarcinoma(PDAC)cellsandbindsavidlytoCHK1(97%bindingat1.0µM)[1].MA203(2µM,24h)highlysignificantlyattenuatesCHK1levelsbyupto80%and50%inHydroxyurea(HY-B0313)(HU)-treatedMIAPaCa-2andMOLT-4cells[1].MA203(2μM,3-24h)-mediatedCHK1degradationisatime-dependenteventaccompaniedbychangesinphosphorylationstateinMIAPaCa-2cells,indicatingthatdegradationenhancesDNAdamagesignals[1].MA203plusHUreducesCHK1significantlyto50%-40%ofitslevelsinuntreatedcellsinMOLT-4cells,MOLM-13cells,RS4-11cells,HCT116cellsandattenuatesCHK1levelsinMOLM-13cells[1].MA203(1-5µM,24h)dose-dependentlyattenuatesCHK1moreefficientlywhencombinedwith5µMIrinotecan(HY-16562)thanwhenusedaloneinMIAPaCa-2cells[1].MA203(0.5-10µM,24h)exhibitsasignificantlylowerconcentrationforhalf-maximumCHK1degradationwhencombinedwith2µMCytarabine(HY-13605)(DC50=387.4nM)thanwhenusedalone(DC50=3.86µM)inMOLT-4cells[1].MA203(0.5–10μM,24h)enhancesHU-inducedDNAreplicationstress,leadingtoDNAdouble-strandbreaksandreplicationcatastropheinMIAPaCa-2andMOLT-4cells[1].MA203(2μM,24-48h)+HUsignificantlyincreasestheproportionofcellsundergoingearlyandlate1/3 MasterofBioactiveMolecules—您身边的抑制剂大师www.MedChemEapoptosisinMIAPaCa-2andMOLT-4cells[1].MA203(2µM,24h)aloneandincombinationwithHUpromotestheviabilityofdendriticcells[1].MA203(2µM,24h)substantiallyaugmentsAra-C-mediatedcelldeath,evidencedbya62%decreaseintheAra-Cconcentrationneededtokill50%ofMOLT-4cells(IC50)inMOLT-4cells[1].MA203(2µM,24h)+HUfor24hyieldsauniqueandobviousreductionofseveralkeyproteinsthatcontroltumorigenesisandDNAdamagerepair,includingtranscriptionfactor-7(TCF7),celldivisioncycle-associated-7(CDCA7),originrecognitioncomplexsubunit-1(ORC1),andWernersyndromeRecQ-likehelicase(WRN)andweaklyaugmentedRRM2levelsinMIAPaCa-2cells[1].MA203(2µM,24-48h)+HUleadstostrongerG1/Sphasearrest;inducesahigherapoptosisrate,accompaniedbyupregulationofBAX/BIManddownregulationofBCL-XL/XIAP;moresignificantlossofmitochondrialmembranepotentialandstrongercaspaseactivationinMIAPaCa-2cells[1].WesternBlotAnalysis[1]CellLine:MIAPaCa-2cells,MOLT-4cellsConcentration:2µMIncubationTime:24hResult:SpecificallydegradedCHK1,andthisdegradationisenhancedbyHU-inducedCHK1activation.DidnotaffectothercheckpointkinasesorcommonCRBNsubstrates.WesternBlotAnalysis[1]CellLine:MIAPaCa-2cellsConcentration:2µMIncubationTime:3h,6h,10h,16h,24hResult:IllustratedthatthedegradationofCHK1startedalreadyafter3hinMIAPaCa-2cells,toyielda50%-70%reductionofCHK1after10-16h.SuppressedtheHU-inducedhyperphosphorylationofCHK1atS296butaugmenteditsHU-inducedhyperphosphorylationatS345.DidnotalterCHK2levelsoverdifferenttimepoints.WesternBlotAnalysis[1]CellLine:MIAPaCa-2,MOLT-4Concentration:0.5μM,1μM,2μM,5μM,10μMIncubationTime:24hResult:SignificantlyincreasedγH2AXlevels(4.2-fold).AchievedaDmaxof92%ataDC50of1.51µMinMIAPaCa-2cells,andaDmaxof2/3 MasterofBioactiveMolecules—您身边的抑制剂大师www.MedChemE93.2%ataDC50of5.35µMinMOLT-4cells.Significant15.7-foldinductionofATMphosphorylationatS1981.ApoptosisAnalysis[1]CellLine:MIAPaCa-2cells,HCT116cells,MOLT-4cells,MOLM-13cellsConcentration:2μMIncubationTime:24h,48hResult:After48h,thepercentagesofearlyandlateapoptoticcellssignificantlyincreasedto15%and14%inMIAPaCa-2cellcultures;Asignificantriseintheearlyapoptoticcellpopulationto33%wasobserved.InHCT116cells,causedearlyandlateapoptosisweresignificantlyincreasedwhencombinedwith0.5mMHUfor48h.Anaccumulationoflateapoptoticcells(30%)occurredupontreatment.Significantlyaugmentedcellpopulationsinearlyapoptosisto19%andinlateapoptosisto15%after24hinMOLT-4cells.Inthepresenceof1mMHU,triggeredearly(48%)andlate(24%)apoptoticcelldeath.InMOLM-13cells,triggeredasignificantaccumulationofearlyapoptoticcells(33%),enhancedlateapoptosisofMOLM-13cellsto50%.Normalhumancellsdidnotexhibitanysignificantimpairmentinviabilityupontreatment.体内研究MA203(PROTAC41)(12μM,48h)significantlyinhibitstheproliferationofhumanleukemiacellsinzebrafishlarvae,andshowsnosignificanttoxicitytozebrafishlarvaeateffectivedoses[1].REFERENCESAshryR,etal.IdentificationofaProteolysis-Targeting-ChimerathatAddressesActivatedCheckpointKinase-1RevealsitsNon-CatalyticFunction
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 深度解析(2026)《GBT 34288-2017拳击台技术与安装要求》
- 2026年八年级道德与法治上册期末考试试卷及答案(二)
- 2026年南平市医疗类储备人才引进备考题库及完整答案详解一套
- 2026年阳宗海风景名胜区“社会救助服务人员”公开招聘备考题库及答案详解一套
- 2026年贵州医科大学附属乌当医院招聘合同制员工7人备考题库及完整答案详解一套
- 新余市数字产业投资发展有限公司2025年度招聘备考题库及一套答案详解
- 2026年南县城乡发展投资有限公司公开招聘备考题库及参考答案详解一套
- 2026年兰溪市中医院第一批面向高校公开招聘医学类应届毕业生的备考题库及完整答案详解1套
- 2026年多岗招人蜀道集团直属子公司招聘→备考题库及答案详解参考
- 2026年临沂高新区法律顾问选聘备考题库完整答案详解
- 大学校园网网络设计及规划方案
- HGT21581-2012 自控安装图册
- 标识标牌制作服务方案
- JBT 7927-2014 阀门铸钢件外观质量要求
- 胃肠镜健康宣教胃肠镜检查注意事项适应症与禁忌症宣传课件
- 麻醉与复苏技术教案课件
- 专题10 几何图形初步中动角问题压轴题真题分类(原卷版)-2023-2024学年七年级数学上册重难点题型分类高分必刷题(人教版)
- 家用吸尘器测试标准
- 高低温测试报告表
- 新人教版四年级上册数学同步练习册
- 《两次鸦片战争》同步练习
评论
0/150
提交评论